Dominant cytotoxic T lymphocyte response to the immediate-early transactivator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection

Journal of Infectious Diseases

Volumn 176, Issue 4, 1997, Pages 1068-1072

  Elliott, Suzanne L ^a,b   Pye, Stephanie J ^a   Schmidt, Chris ^a   Cross, Simone M ^a   Silins, Sharon L ^a   Misko, Ihor S ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; EPITOPE; EPSTEIN BARR VIRUS VACCINE; HLA B8 ANTIGEN; IMMEDIATE EARLY PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; INFECTIOUS MONONUCLEOSIS; LYMPHOBLAST; MEMORY CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL; VIRUS CARRIER;

EID: 0030765366     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516513     Document Type: Article

References (15)

1. Khanna R, Burrow SR, Moss DJ. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev 1995;59:387-405.
2. Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 1984;310:1225-30.
3. Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 1995;85:744-50.
4. Yao QY, Rickinson AB, Epstein MA. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer 1985;35:35-42.
5. Bourgault I, Gomez A, Gomard E, Levy JP. Limiting-dilution analysis of the HLA restriction of anti-Epstein-Barr virus-specific cytolytic T lymphocytes. Clin Exp Immunol 1991;84:501-7.
6. Yao QY, Rickinson AB, Gaston JSH, Epstein MA. In vitro analysis of the Epstein-Barr virus:host balance in long-term renal allograft recipients. Int J Cancer 1985;35:43-9.
7. Bogedain C, Wolf H, Modrow S, Stuber G, Jilg W. Specific cytotoxic T lymphocytes recognize the immediate-early trans-activator Zta of Epstein-Barr virus. J Virol 1995;69:4872-9.
8. + virus-specific cytotoxic T cells which recognize Epstein-Barr virus lytic antigen BHRF1. Virology 1996;219:489-92.
9. Schmidt C, Burrows SR, Sculley TB, Moss DJ, Misko IS. Nonresponsiveness to an immunodominant Epstein-Barr virus-encoded cytotoxic T-lymphocyte epitope in nuclear antigen 3A: implications for vaccine strategies. Proc Natl Acad Sci USA 1991;88:9478-82.
10. Burrows SR, Misko IS, Sculley TB, Schmidt C, Gang D, Moss DJ. Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformants. Cell Immunol 1990;127:47-55.
11. Gratama JW, Oosterveer MAP, Zwaan FE, Lepoutre J, Klein G, Ernberg I. Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc Natl Acad Sci USA 1988;85:8693-6.
12. Joab I, Triki H, de Saint Martin J, Perricaudet M, Nicolas JC. Detection of Anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus. J Infect Dis 1991; 163:53-6.
13. Joab I, Nicolas JC, Schwaab G, et al. Detection of anti-Epstein-Barr-virus trans-activator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer 1991;48:647-9.
14. Becker J, Leser U, Marschall M, et al. Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. Proc Natl Acad Sci USA 1991;88:8332-6.
15. Gonnella R, Angeloni A, Calogero A, et al. Transcription of latent and replicative Epstein-Barr-Virus genes in bone-marrow and peripheral-blood mononuclear cells of healthy donors. Int J Cancer 1997;70:524-9.